Dr. Nanus on Trials Investigating Immunotherapy in RCC – OncLive
|
Dr. Nanus on Trials Investigating Immunotherapy in RCC
OncLive David M. Nanus, MD, medical oncologist, Weill Cornell Medicine/NewYork-Presbyterian Hospital, discusses trials investigating immunotherapy regimens for patients with renal cell carcinoma (RCC). There are several phase III upfront randomized trials of … |
